Location: Dallas, TX
CIK: 0001791827 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value: $4.715B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 1,985,000 | $269M | 5.7% | $82.28 | +23.6% | COM | 00287Y109 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 2,715,000 | $228M | 4.8% | $49.45 | +56.5% | COM | 98943L107 |
| ARVN | ARVINAS INC | 2,527,973 | $208M | 4.4% | $52.10 | +56.2% | COM | 04335A105 |
| AVTR | AVANTOR INC | 4,792,000 | $202M | 4.3% | $27.33 | +44.2% | COM | 05352A100 |
| AZN | ASTRAZENECA PLC | 2,867,200 | $167M | 3.5% | $59.14 | — | SPONSORED ADR | 046353108 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 1,140,000 | $157M | 3.3% | $79.44 | — | COM | G11196105 |
| BAX | BAXTER INTL INC | 1,765,000 | $152M | 3.2% | $72.39 | +1.1% | COM | 071813109 |
| ELV | ANTHEM INC | 321,000 | $149M | 3.2% | $397.15 | 0.0% | COM | 036752103 |
| PFE | PFIZER INC | 2,090,000 | $123M | 2.6% | $37.99 | +5.9% | COM | 717081103 |
| — | MIRATI THERAPEUTICS INC | 806,400 | $118M | 2.5% | $173.80 | — | COM | 60468T105 |
| — | IVERIC BIO INC | 6,955,000 | $116M | 2.5% | $14.44 | — | COM | 46583P102 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 535,000 | $116M | 2.5% | $193.87 | +1.3% | COM | 91307C102 |
| — | ARENA PHARMACEUTICALS INC | 1,215,500 | $113M | 2.4% | $73.04 | — | COM NEW | 040047607 |
| — | HORIZON THERAPEUTICS PUB L | 1,012,000 | $109M | 2.3% | $81.45 | — | SHS | G46188101 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,260,000 | $107M | 2.3% | $96.16 | -4.3% | COM | 64125C109 |
| — | BLUEPRINT MEDICINES CORP | 995,000 | $107M | 2.3% | $103.79 | — | COM | 09627Y109 |
| — | SEAGEN INC | 685,000 | $106M | 2.2% | $143.71 | — | COM | 81181C104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 4,823,400 | $106M | 2.2% | $18.27 | +1.2% | COM | 87164F105 |
| LLY | LILLY ELI & CO | 344,800 | $95.24M | 2.0% | $194.13 | +25.6% | COM | 532457108 |
| — | CATALENT INC | 695,000 | $88.98M | 1.9% | $108.60 | — | COM | 148806102 |
| NTRA | NATERA INC | 940,000 | $87.79M | 1.9% | $86.31 | +20.2% | COM | 632307104 |
| HOLX | HOLOGIC INC | 1,064,000 | $81.46M | 1.7% | $67.59 | +8.7% | COM | 436440101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 3,780,000 | $72.16M | 1.5% | $22.61 | -2.6% | COM | 462260100 |
| SHC | SOTERA HEALTH CO | 2,960,000 | $69.71M | 1.5% | $25.22 | -5.1% | COM | 83601L102 |
| NUVB | NUVATION BIO INC | 7,382,488 | $62.75M | 1.3% | $11.06 | -16.9% | COM CL A | 67080N101 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 370,000 | $62.74M | 1.3% | $170.64 | +8.9% | COM | 02043Q107 |
| UNH | UNITEDHEALTH GROUP INC | 123,100 | $61.81M | 1.3% | $422.19 | 0.0% | COM | 91324P102 |
| VRTX | VERTEX PHARMACEUTICALS INC | 280,000 | $61.49M | 1.3% | $214.12 | -9.2% | COM | 92532F100 |
| IDYA | IDEAYA BIOSCIENCES INC | 2,553,000 | $60.35M | 1.3% | $20.35 | +14.1% | COM | 45166A102 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 700,000 | $58.86M | 1.2% | $87.23 | -6.7% | COM | 90400D108 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 875,000 | $58.01M | 1.2% | $66.81 | +2.8% | COM | 04280A100 |
| STVN | STEVANATO GROUP S P A | 2,541,893 | $57.06M | 1.2% | $23.29 | +0.7% | ORD SHS | T9224W109 |
| — | GRITSTONE BIO INC | 4,370,000 | $56.2M | 1.2% | $7.53 | — | COM | 39868T105 |
| — | KEZAR LIFE SCIENCES INC | 3,228,200 | $53.98M | 1.1% | $16.07 | — | COM | 49372L100 |
| — | ADICET BIO INC | 3,034,004 | $53.06M | 1.1% | $13.68 | — | COM | 007002108 |
| RNAM | AVIDITY BIOSCIENCES INC | 1,815,000 | $43.14M | 0.9% | $21.94 | +8.9% | COM | 05370A108 |
| KYMR | KYMERA THERAPEUTICS INC | 670,000 | $42.54M | 0.9% | $58.04 | +0.4% | COM | 501575104 |
| IMCR | IMMUNOCORE HLDGS PLC | 1,230,000 | $42.12M | 0.9% | $39.30 | — | ADS | 45258D105 |
| CRBU | CARIBOU BIOSCIENCES INC | 2,674,067 | $40.35M | 0.9% | $24.07 | -19.2% | COM | 142038108 |
| INSM | INSMED INC | 1,450,000 | $39.5M | 0.8% | $29.22 | -2.2% | COM PAR $.01 | 457669307 |
| — | ORTHO CLINICAL DIAGNOSTICS H | 1,790,000 | $38.29M | 0.8% | $18.48 | — | ORD SHS | G6829J107 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1,896,000 | $37.29M | 0.8% | $23.53 | 0.0% | COM | 71722W107 |
| — | ESSA PHARMA INC | 2,460,000 | $34.93M | 0.7% | $9.93 | — | COM NEW | 29668H708 |
| AMN | AMN HEALTHCARE SVCS INC | 280,100 | $34.27M | 0.7% | $111.02 | 0.0% | COM | 001744101 |
| LEGN | LEGEND BIOTECH CORP | 711,900 | $33.18M | 0.7% | $43.91 | — | SPONSORED ADS | 52490G102 |
| ATEC | ALPHATEC HLDGS INC | 2,773,000 | $31.7M | 0.7% | $12.16 | -2.9% | COM NEW | 02081G201 |
| — | BELLUS HEALTH INC NEW | 3,775,000 | $30.39M | 0.6% | $3.60 | — | COM NEW | 07987C204 |
| VIR | VIR BIOTECHNOLOGY INC | 700,000 | $29.31M | 0.6% | $42.71 | -8.3% | COM | 92764N102 |
| AXSM | AXSOME THERAPEUTICS INC | 775,000 | $29.28M | 0.6% | $36.79 | 0.0% | COM | 05464T104 |
| — | SEASPINE HLDGS CORP | 2,010,000 | $27.38M | 0.6% | $19.29 | — | COM | 81255T108 |
| ALT | ALTIMMUNE INC | 2,765,000 | $25.33M | 0.5% | $11.83 | -10.2% | COM NEW | 02155H200 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,278,261 | $25.27M | 0.5% | $18.63 | 0.0% | COM | 92790C104 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 862,000 | $25.23M | 0.5% | $29.27 | — | COM | 37890U108 |
| — | CHEMOCENTRYX INC | 644,400 | $23.46M | 0.5% | $36.41 | — | COM | 16383L106 |
| SIBN | SI-BONE INC | 987,400 | $21.93M | 0.5% | $24.15 | -10.9% | COM | 825704109 |
| — | CYTEIR THERAPEUTICS INC | 1,849,538 | $21.03M | 0.4% | $20.50 | — | COM | 23284P103 |
| — | ALPINE IMMUNE SCIENCES INC | 1,345,000 | $18.63M | 0.4% | $10.31 | — | COM | 02083G100 |
| RLMD | RELMADA THERAPEUTICS INC | 731,536 | $16.48M | 0.3% | $22.24 | 0.0% | COM | 75955J402 |
| SCYX | SCYNEXIS INC | 2,239,278 | $13.66M | 0.3% | $6.60 | -6.9% | COM NEW | 811292200 |
| IPSC | CENTURY THERAPEUTICS INC | 851,522 | $13.51M | 0.3% | $24.51 | -23.3% | COM | 15673T100 |
| — | PHASEBIO PHARMACEUTICALS INC | 4,405,000 | $11.5M | 0.2% | $3.45 | — | COM | 717224109 |
| HYPR | HYPERFINE INC | 1,514,410 | $10.98M | 0.2% | $9.78 | 0.0% | COM CL A | 44916K106 |
| S | SENTINELONE INC | 208,000 | $10.5M | 0.2% | $43.12 | +35.9% | CL A | 81730H109 |
| — | GRAPHITE BIO INC | 710,000 | $8.825M | 0.2% | $30.47 | — | COM | 38870X104 |
| — | FIELD TRIP HEALTH LTD | 3,205,000 | $7.884M | 0.2% | $4.59 | — | COM | 31656R102 |
| TNGX | TANGO THERAPEUTICS INC | 705,000 | $7.713M | 0.2% | $12.01 | +0.1% | COM | 87583X109 |
| ACAD | ACADIA PHARMACEUTICALS INC | 300,000 | $7.002M | 0.1% | $22.57 | -10.9% | COM | 004225108 |
| — | INSTIL BIO INC | 408,140 | $6.983M | 0.1% | $24.94 | — | COM | 45783C101 |
| — | TALARIS THERAPEUTICS INC | 455,037 | $6.958M | 0.1% | $14.64 | — | COM | 87410C104 |
| DH | DEFINITIVE HEALTHCARE CORP | 250,000 | $6.833M | 0.1% | $34.98 | 0.0% | CLASS A COM | 24477E103 |
| — | EQRX INC | 1,000,000 | $6.82M | 0.1% | $6.82 | — | COM | 26886C107 |
| — | CAREMAX INC | 827,402 | $6.354M | 0.1% | $12.86 | — | COM CL A | 14171W103 |
| CMPX | COMPASS THERAPEUTICS INC | 2,000,000 | $6.34M | 0.1% | $3.29 | 0.0% | COM | 20454B104 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 300,000 | $6.126M | 0.1% | $20.37 | +2.8% | COM | 61225M102 |
| HOWL | WEREWOLF THERAPEUTICS INC | 485,000 | $5.776M | 0.1% | $13.70 | +10.2% | COM | 95075A107 |
| — | MEDICUS SCIENCES ACQUISITION | 520,000 | $5.039M | 0.1% | $9.65 | — | CL A SHS | G5960S108 |
| — | ARYA SCIENCES ACQU CORP IV | 500,000 | $4.958M | 0.1% | $10.47 | — | CL A | G31659108 |
| — | DYNAMICS SPECIAL PURPOSE COR | 500,000 | $4.93M | 0.1% | $9.94 | — | CLASS A COM | 268010105 |
| — | SCIENCE 37 HOLDINGS INC | 394,000 | $4.913M | 0.1% | $12.47 | — | COM | 808644108 |
| — | BCLS ACQUISITION CORP | 500,000 | $4.9M | 0.1% | $11.14 | — | COM CL A | G0904B105 |
| — | PANACEA ACQUISITION CORP II | 500,000 | $4.85M | 0.1% | $10.02 | — | CL A SHS | G6882C106 |
| TRDA | ENTRADA THERAPEUTICS INC | 255,000 | $4.366M | 0.1% | $17.12 | — | COM | 29384C108 |
| — | SEMA4 HOLDINGS CORP | 950,000 | $4.237M | 0.1% | $7.59 | — | COM CL A | 81663L101 |
| — | HEALTH SCIENCES ACQ CORP 2 | 400,000 | $4.032M | 0.1% | $11.00 | — | ORD SHS | G4411D109 |
| MLTX | HELIX ACQUISITION CORP | 400,000 | $3.956M | 0.1% | $11.37 | — | COM CL A | G4444C102 |
| — | SOMALOGIC INC | 330,000 | $3.841M | 0.1% | $12.39 | — | CLASS A COM | 83444K105 |
| — | MERUS N V | 103,000 | $3.275M | 0.1% | $31.80 | — | COM | N5749R100 |
| — | ONCOSEC MED INC | 2,945,000 | $2.826M | 0.1% | $5.54 | — | COM | 68234L306 |
| — | SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $1.986M | 0.0% | $10.11 | — | CLASS A ORD SHS | G8253T106 |
| — | SOCIAL CAP SUVRETTA HLD CRPI | 200,000 | $1.98M | 0.0% | $10.11 | — | CLASS A ORD SHS | G8253W109 |
| — | SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $1.978M | 0.0% | $10.12 | — | CLASS A ORD SHS | G8253U103 |
| — | SOCIAL CAP SUVRETTA HLDS CP | 200,000 | $1.964M | 0.0% | $10.10 | — | CLASS A ORD SHS | G8253Y105 |
| STTK | SHATTUCK LABS INC | 165,000 | $1.404M | 0.0% | $32.73 | -57.9% | COM | 82024L103 |
| — | ZIOPHARM ONCOLOGY INC | 590,000 | $643K | 0.0% | $1.82 | — | COM | 98973P101 |
| — | SOMALOGIC INC | 65,999 | $220K | 0.0% | $3.45 | — | *W EXP 08/31/202 | 83444K113 |
| — | NUVATION BIO INC | 99,999 | $189K | 0.0% | $2.67 | — | *W EXP 07/07/202 | 67080N119 |
| — | MEDICUS SCIENCES ACQUISITION | 57,770 | $42,000 | 0.0% | $1.00 | — | *W EXP 02/12/202 | G5960S124 |